Showing results (61-70 of 149) with videos related to
Sort By:
Pageof 15
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2006
Presence of FLT3 mutations does not impair stem cell mobilization and feasibility of autologous peripheral blood stem cell transplantation in acute myeloid leukemiaFelicetto Ferrara, Salvatore Palmieri, Filiberto Pollio, et al.Tumori|March 10, 2023
Acute myeloid leukemia: Incidence, transplantation and survival through Italian administrative healthcare dataSilvia Calabria, Giulia Ronconi, Letizia Dondi, et al.The Hematology Journal : the Official Journal of the European Haematology Association|May 29, 2004
Outpatient-based peripheral blood stem cell transplantation for patients with multiple myelomaFelicetto Ferrara, Salvatore Palmieri, Assunta Viola, et al.Leukemia & Lymphoma|September 17, 2004
Ifosfamide, epirubicin and etoposide (IEV) regimen as salvage and mobilization therapy for refractory or early relapsing patients with aggressive non-Hodgkin's lymphomaBarbara Pocali, Mariacarla De Simone, Mario Annunziata, et al.Hematological Oncology|October 13, 2006
Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotypeSalvatore Palmieri, Felicetto Ferrara, Franco Leoni, et al.European Journal of Haematology|June 20, 2002
De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G-CSF (FLAG)Felicetto Ferrara, Salvatore Palmieri, Barbara Pocali, et al.Leukemia Research Reports|July 22, 2024
Real-world treatments and clinical outcomes in unfit AML patients receiving first-line treatment or best supportive care in Italy (CURRENT study)Maria Paola Martelli, Nicola Di Renzo, Antonio Curti, et al.Blood Reviews|April 12, 2025
Navigating acute myeloid leukemia towards better outcomes: Treatment pathways and challenges for patients ineligible for intensive chemotherapyRaffaele Palmieri, Anna Candoni, Francesco Di Raimondo, et al.Leukemia & Lymphoma|June 24, 2008
R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: a pilot studyGiuseppe Visani, Felicetto Ferrara, Francesco Alesiani, et al.European Journal of Haematology|November 15, 2002
Autologous stem-cell transplantation for patients with acute myeloid leukemia aged over 60 yrFelicetto Ferrara, Adriano Venditti, Angelo Michele Carellajr, et al.Pageof 15